Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$1.63 - $2.55 $17,930 - $28,049
-11,000 Closed
0 $0
Q3 2021

Oct 29, 2021

SELL
$2.45 - $4.1 $30,625 - $51,249
-12,500 Reduced 53.19%
11,000 $34,000
Q2 2021

Jul 26, 2021

SELL
$3.0 - $4.39 $6,000 - $8,780
-2,000 Reduced 7.84%
23,500 $91,000
Q1 2021

Apr 27, 2021

BUY
$2.2 - $5.05 $56,100 - $128,775
25,500 New
25,500 $91,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $105M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.